A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia
Authors: Czardybon, W., Windak, R., Golas, A., Galezowski, M., Sabiniarz, A., Dolata, I., Salwinska, M., Guzik, P., Zawadzka, M., Gabor-Worwa, E., Winnik, B., Zurawska, M., Kolasinska, E., Wincza, E., Bugaj, M., Danielewicz, M., Majewska, E., Mazan, M., Dubin, G., Noyszewska-Kania, M., Jablonska, E., Szydlowski, M., Sewastianik, T., Pula, B., Szumera-Cieckiewicz, A., Prochorec-Sobieszek, M., Madro, E., Lech-Maranda, E., Warzocha, K., Tamburini, J., Juszczynski, P., Brzozka, K.
Published in: Oncotarget
Publication type: article
Subject areas: Medicine
SJR best quartile: Q2